mAbs
Μορφή: | journal |
---|---|
Γλώσσα: | English |
Έκδοση: |
Taylor & Francis Group
2021
|
Θέματα: | |
Διαθέσιμο Online: | https://doaj.org/toc/1942-0870 |
id |
oai:doaj.org-journal:35d219da09c84009a1af37a5f3f7bc9e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-journal:35d219da09c84009a1af37a5f3f7bc9e2023-07-18T15:26:08ZmAbs1942-08701942-0862https://doaj.org/toc/1942-0870ENCC BYCC BY-NCTaylor & Francis Grouphttps://www.tandfonline.com/journals/kmabhttps://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=kmab20https://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmab202021-05-10T13:02:02Zjournalimmunologyantibodiescancerantibody therapeuticsantibody engineeringTherapeutics. PharmacologyRM1-950Immunologic diseases. AllergyRC581-607 |
institution |
DOAJ |
collection |
DSpace |
language |
English |
topic |
immunology antibodies cancer antibody therapeutics antibody engineering Therapeutics. Pharmacology RM1-950 Immunologic diseases. Allergy RC581-607 |
spellingShingle |
immunology antibodies cancer antibody therapeutics antibody engineering Therapeutics. Pharmacology RM1-950 Immunologic diseases. Allergy RC581-607 mAbs |
format |
journal |
title |
mAbs |
title_short |
mAbs |
title_full |
mAbs |
title_fullStr |
mAbs |
title_full_unstemmed |
mAbs |
title_sort |
mabs |
publisher |
Taylor & Francis Group |
publishDate |
2021 |
url |
https://doaj.org/toc/1942-0870 |
_version_ |
1801185051912699904 |